| scholarly article | Q13442814 |
| P50 | author | Esther Oliva | Q124080506 |
| Judy E. Garber | Q60668203 | ||
| P2093 | author name string | Alexander Miron | |
| Annekathryn Goodman | |||
| Yosuf Yassin | |||
| Christopher P Crum | |||
| Wa Xian | |||
| Ross S Berkowitz | |||
| Michael Roh | |||
| Bradley J Quade | |||
| Karishma Mehra | |||
| Dana R Semmel | |||
| P2860 | cites work | Two genetic hits (more or less) to cancer | Q22251289 |
| p63 Is essential for the proliferative potential of stem cells in stratified epithelia | Q28300720 | ||
| The cell of origin of ovarian epithelial tumours | Q28302089 | ||
| A candidate precursor to serous carcinoma that originates in the distal fallopian tube. | Q33264156 | ||
| Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities | Q33315604 | ||
| Prevention of ovarian cancer | Q33602394 | ||
| Rules for making human tumor cells | Q34159004 | ||
| Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. | Q34519901 | ||
| A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations | Q34761925 | ||
| Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations | Q34811314 | ||
| Pathologic findings in prophylactic oophorectomy specimens in high-risk women | Q35018111 | ||
| Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. | Q35910484 | ||
| Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair | Q36159147 | ||
| The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss | Q36649149 | ||
| Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction | Q36924865 | ||
| Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention | Q37125079 | ||
| Radiation-sensitive genetically susceptible pediatric sub-populations | Q37130076 | ||
| Critical molecular abnormalities in high-grade serous carcinoma of the ovary | Q37232123 | ||
| Epithelial ovarian cancer: focus on genetics and animal models | Q37394549 | ||
| The Li-Fraumeni syndrome: an inherited susceptibility to cancer | Q41596904 | ||
| Methylation not a frequent "second hit" in tumors with germline BRCA mutations. | Q44455213 | ||
| Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. | Q46016693 | ||
| BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? | Q46554691 | ||
| High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. | Q51742087 | ||
| Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. | Q51842388 | ||
| Serous carcinogenesis in the fallopian tube: a descriptive classification. | Q53325750 | ||
| Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. | Q53337533 | ||
| Early de novo ovarian carcinoma. A study of fourteen cases. | Q53473244 | ||
| Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human fallopian tube | Q74081573 | ||
| Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors | Q74495336 | ||
| P433 | issue | 1 | |
| P921 | main subject | Li-Fraumeni syndrome | Q187542 |
| uterine tube | Q1233836 | ||
| P304 | page(s) | 17-23 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube | |
| P478 | volume | 220 |
| Q84656119 | Bringing the p53 signature into focus |
| Q36059087 | Do hereditary syndrome-related gynecologic cancers have any specific features? |
| Q36916354 | Evaluating the progenitor cells of ovarian cancer: analysis of current animal models. |
| Q35560963 | Fallopian tube correlates of ovarian serous borderline tumors |
| Q34253391 | MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. |
| Q46670778 | Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis |
| Q43195521 | Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice. |
| Q45068704 | Ovarian Cancer Prevention in High-risk Women |
| Q26822545 | Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis |
| Q89923260 | Serous tubal intraepithelial neoplasia: the concept and its application |
| Q35209384 | Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. |
| Q57139134 | Surgical prevention strategies in ovarian cancer |
| Q55053523 | The genesis and evolution of high-grade serous ovarian cancer |
| Q53294992 | The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls. |
| Q27008375 | The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin |
| Q37626525 | Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer. |
| Q84644895 | [Preneoplasias of ovarian carcinoma: biological and clinical aspects of different pathways of tumorigenesis] |
Search more.